The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]

  • See Evidence submitted by expert panel for details.

Variant: NM_000277.3(PAH):c.1200-1G>A

CA220577

92730 (ClinVar)

Gene: PAH
Condition: phenylketonuria
Inheritance Mode: Autosomal recessive inheritance
UUID: 3ef13555-39cd-454f-bafb-aa98f5ede6c9

HGVS expressions

NM_000277.3:c.1200-1G>A
NM_000277.3(PAH):c.1200-1G>A
NM_000277.1:c.1200-1G>A
NM_000277.2:c.1200-1G>A
NM_001354304.1:c.1200-1G>A
NM_001354304.2:c.1200-1G>A
ENST00000307000.7:c.1185-1G>A
ENST00000549247.6:n.959-1G>A
ENST00000551114.2:n.862-1G>A
ENST00000553106.5:c.1200-1G>A
ENST00000635477.1:n.304-1G>A
ENST00000635528.1:n.715-1G>A
NC_000012.12:g.102840516C>T
CM000674.2:g.102840516C>T
NC_000012.11:g.103234294C>T
CM000674.1:g.103234294C>T
NC_000012.10:g.101758424C>T
NG_008690.1:g.82087G>A
NG_008690.2:g.122895G>A

Pathogenic

Met criteria codes 4
PM2 PM3 PVS1 PP4

Evidence Links 1

Expert Panel

Criteria Specification Information

Criteria Specifications for this VCEP
Evidence submitted by expert panel
Phenylketonuria VCEP
This c.1200-1G>A variant in PAH was reported in 2 Caucasian patients with PAH deficiency (PMID: 23430918) detected with pathogenic variants p.Phe55Leu and c.1315+1G>A. A defect in BH4 metabolism was not excluded. This variant is absent from population databases. This variant in the -1 splice acceptor site results in exon skipping, which disrupts the reading frame and is predicted to undergo nonsense mediated decay. The exon is present in biologically-relevant transcripts. In summary, this variant meets criteria to be classified as pathogenic for PAH. PAH-specific ACMG/AMP criteria applied: PVS1, PM2, PM3, PP4.
Met criteria codes
PM2
PM2_met: This variant is absent from population databases gnomAD and ExAC.
PM3
PM3_met: This variant was detected with pathogenic variants in 2 patients with PAH deficiency (PMID: 23430918). 23430918 - This variant was detected in trans with the pathogenic PAH variant p.Phe55Leu in 1 Caucasian patient with PAH deficiency. This variant was detected in trans with the pathogenic PAH variant c.1315+1G>A in 1 Caucasian patient with PAH deficiency. Parental analysis was not performed to confirm compound heterozygosity.
PVS1
PVS1_met: This variant in the -1 splice acceptor site of IVS11 results in exon skipping or use of a cryptic splice site. The variant disrupts the reading frame and is predicted to undergo nonsense mediated decay (NMD). The exon is present in biologically-relevant transcripts. This variant breaks the splice site in IVS11 according to Splice AI (0.95 - splice-altering) and TraP (0.581, >99%ile, probably damaging).
PP4
PP4_met: This variant was documented in 2 patients with PAH deficiency (PMID: 23430918). 23430918, Sarkissian - This variant was documented in 2 Caucasian patients with PAH deficiency. All PKU patients included in this study had phenylalanine plasma concentrations >120 μM as described in the clinical trial protocols. A defect in BH4 metabolism was not excluded through a BH4 loading test, urinary pterin analysis and DHPR activity assay.

Approved on: 2020-10-15
Published on: 2020-10-15
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.